These modified HCV NS3 proteins have advantageous properties both for diagnostic and therapeutic/prophylactic applications.doi:EP1481985 A1Depla ErikMaertens GeertBosman FonsEPEP1481985A1 * May 28, 2004 Dec 1, 2004 Innogenetics N.V. Modified hepatitis C virus (HCV) NS3 for medical treatment...
Since then over 130 agents, many of which are available in single-pill combinations, have been approved by the FDA for the treatment of hypertension. Each of these agents uses one or more of the 17 mechanisms of action to lower BP [2]. Antihypertensive drug development and approval began ...
Knowledge of HCV infection alone does not mean that IDUs will seek medical care. Additional education concerning medical care and treatment options are needed to address IDU needs. 展开 关键词: hepatitis C injection drug users and medical care referrals ...
eleazer1827over a year ago I have been recently diagnosed with hepatitis C. I am on diet, taking supplements, but I would like o know what is most important that I should know with hepatitis. Also I would like to know what Chinese medicine says about hepatitis. ...
Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral He... The aim of this study was to evaluate whether interferon alfa (IFN-伪) treatment-associated virological and biochemical remission improves ...
Introduction: The significance of hepatitis C infection in Poland, particularly in a pathology of the developmental age still increased. The aim of the study was the analysis of interferon alpha therapy efficacy in children with chronic C hepatitis.Mater
"Today’s pills have double the viral cure rates—90% to 100%—in just in 12 weeks’ time.Reducing the treatment from a year to three months is a huge advantage for people with hepatitis C, especially because it’s easier to swallow a pill than to get an injection."- Jeffrey S. Mur...
Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities Annie Pedlar,Prabjot (Jodie) S... - 《Journal of the American Association of Nurse Practitioners》 - 2019 - 被引量: 0 PREVALENCE OF HEPATITIS-C ANT...
Recently approved direct-acting antiviral medications have transformed treatment for individuals withhepatitisC virus (HCV), and are effective in over 90% of cases. The antivirals have the potential to significantly reduce or eliminate HCV in two ways: through treatment to prevent HCV-related complica...
The invention provides a method of treating a patient infected with hepatitis C virus (HCV) comprising raising the core temperature of the patient and then returning the core temper